Answers are grounded in this paper and cite their sources.
Cohn JN : Introduction to surrogate markers. Circulation 2004; 109 ( 25 Suppl 1): IV20–IV21. PubMed Google Scholar Cohn JN, Quyyumi AA, Hollenberg NK, Jamerson KA : Surrogate markers for cardiovascular disease: functional markers. Circulation 2004; 109 ( 25 Suppl 1): IV31–IV46. PubMed Google Scholar Oliver JJ, Webb DJ : Noninvasive assessment of arterial stiffness and risk of atherosclerotic events. Arterioscler Thromb Vasc Biol 2003; 23 : 554–566. Article CAS Google Scholar Yamashina A, Tomiyama H, Takeda K, et al : Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement. Hypertens Res 2002; 25 : 359–364. Article Google Scholar Naka KK, Tweddel AC, Doshi SN, Goodfellow J, Henderson AH : Flow-mediated changes in pulse wave velocity: a new clinical measure of endothelial function. Eur Heart J 2006; 27 : 302–309. Article Google Scholar Jensen JS, Feldt-Rasmussen B, Strandgaard S, Schroll M, Borch-Johnsen K : Arterial hypertension, microalbuminuria, and risk of ischemic heart disease. Hypertension 2000; 35 : 898–903. Article CAS Google Scholar Laurent S, Boutouyrie P, Asmar R, et al : Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 2001; 37 : 1236–1241. Article CAS Google Scholar Hillege HL, Fidler V, Diercks GF, et al : Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation 2002; 106 : 1777–1782. Article CAS Google Scholar Makino H, Nakamura Y, Wada J : Remission and regression of diabetic nephropathy. Hypertens Res 2003; 26 : 515–519. Article Google Scholar Arnlov J, Evans JC, Meigs JB, et al : Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study. Circulation 2005; 112 : 969–975. Article Google Scholar Haraldsson B, Sorensson J : Why do we not all have proteinuria? An update of our current understanding of the glomerular barrier. News Physiol Sci 2004; 19 : 7–10. PubMed Google Scholar Camici M : Renal glomerular permselectivity and vascular endothelium. Biomed Pharmacother 2005; 59 ( 1–2): 30–37. Article CAS Google Scholar Bakris G : Proteinuria: a link to understanding changes in vascular compliance? Hypertension 2005; 46 : 473–474. Article CAS Google Scholar Stehouwer CD, Henry RM, Dekker JM, Nijpels G, Heine RJ, Bouter LM : Microalbuminuria is associated with impaired brachial artery, flow-mediated vasodilation in elderly individuals without and with diabetes: further evidence for a link between microalbuminuria and endothelial dysfunction—the Hoorn Study. Kidney Int Suppl 2004; 92 : S42–S44. Article Google Scholar Pedrinelli R, Giampietro O, Carmassi F, et al : Microalbuminuria and endothelial dysfunction in essential hypertension. Lancet 1994; 344 : 14–18. Article CAS Google Scholar Stehouwer CD, Nauta JJ, Zeldenrust GC, Hackeng WH, Donker AJ, den Ottolander GJ : Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non-insulin-dependent diabetes mellitus. Lancet 1992; 340 : 319–323. Article CAS Google Scholar Kohara K, Tabara Y, Tachibana R, Nakura J, Miki T : Microalbuminuria and arterial stiffness in a general population: the Shimanami Health Promoting Program (J-SHIPP) study. Hypertens Res 2004; 27 : 471–477. Article Google Scholar Munakata M, Nunokawa T, Yoshinaga K, Toyota T, J-TOPP Sutdy Group: Brachial-ankle pulse wave velocity is an independent risk factor for microalbuminuria in patients with essential hypertension—a Japanese Trial on the Prognostic Implication of Pulse Wave Velocity (J-TOPP). Hypertens Res 2006; 29 : 515–521. Article Google Scholar Download references
No takes yet. Share an insight, caveat, or question.
Nakamura et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: